| 1 | [SID49681832] | Active | EC50 | 0.104 | Fluorescence Cell-Based Dose Response to Characterize Compounds Cytotoxic to RAS-Dependent BJ-TERT-LT-ST Fibroblast [AID2631, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | EC50 | 0.104 [uM] | | BioAssay | Fluorescence Cell-Based Dose Response to Characterize Compounds Cytotoxic to RAS-Dependent BJ-TERT-LT-ST Fibroblast | | AID | 2631 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID49681832] | Active | Potency | 0.1458 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | Potency | 0.1458 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 3 | [SID49681832] | Active | Potency | 0.1458 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | Potency | 0.1458 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 4 | [SID49681832] | Active | Potency | 0.1458 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | Potency | 0.1458 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 5 | [SID49681832] | Active | Potency | 0.1636 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | Potency | 0.1636 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 6 | [SID49681832] | Active | Potency | 0.1636 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | Potency | 0.1636 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 7 | [SID49681832] | Active | Potency | 0.1636 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | Potency | 0.1636 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 8 | [SID49681832] | Active | Potency | 0.2593 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | Potency | 0.2593 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 9 | [SID49681832] | Active | Potency | 0.2593 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | Potency | 0.2593 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 10 | [SID49681832] | Active | Potency | 0.2593 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | Potency | 0.2593 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 11 | [SID49681832] | Active | Potency | 0.5174 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line [AID686971, Type: confirmatory] | |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | Potency | 0.5174 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line | | AID | 686971 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 12 | [SID49681832] | Active | IC50 | 1.399 | Homologous Recombination - Rad 51_Dose response [AID1435, Type: confirmatory] | RAD51 [Homo sapiens] [gi:49168602] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | IC50 | 1.399 [uM] | | BioAssay | Homologous Recombination - Rad 51_Dose response | | AID | 1435 | | BioAssay type | confirmatory | | Target | RAD51 [Homo sapiens] [gi:49168602] | | PubMed | | | Data Table |  |
|
| 13 | [SID49681832] | Active | IC50 | 1.399 | Homologous Recombination - Rad 51_Dose response [AID1435, Type: confirmatory] | RAD51 [Homo sapiens] [gi:49168602] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | IC50 | 1.399 [uM] | | BioAssay | Homologous Recombination - Rad 51_Dose response | | AID | 1435 | | BioAssay type | confirmatory | | Target | RAD51 [Homo sapiens] [gi:49168602] | | PubMed | | | Data Table |  |
|
| 14 | [SID49681832] | Active | IC50 | 2.64 | High Throughput Screening Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in 7H9 Media [AID449762, Type: confirmatory] | |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | IC50 | 2.64 [uM] | | BioAssay | High Throughput Screening Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in 7H9 Media | | AID | 449762 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 15 | [SID49681832] | Active | Potency | 3.1623 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 16 | [SID49681832] | Active | Potency | 3.1623 | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 17 | [SID49681832] | Active | Potency | 3.2643 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | Potency | 3.2643 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 18 | [SID49681832] | Active | Potency | 3.2643 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | Potency | 3.2643 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 19 | [SID49681832] | Active | Potency | 3.2643 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | Potency | 3.2643 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 20 | [SID49681832] | Active | Potency | 3.2643 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | Potency | 3.2643 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 21 | [SID49681832] | Active | IC50 | 3.53 | Dose response confirmation of uHTS chemical inhibitors of both B-cell and T-cell specific antigen receptor-induced NF-kB activation in a 697B cell line using a luminescence assay [AID489034, Type: confirmatory] | |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | IC50 | 3.53 [uM] | | BioAssay | Dose response confirmation of uHTS chemical inhibitors of both B-cell and T-cell specific antigen receptor-induced NF-kB activation in a 697B cell line using a luminescence assay | | AID | 489034 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 22 | [SID49681832] | Active | IC50 | 5.87 | A High Throughput Confirmatory Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in the absence of Glycerol [AID449764, Type: confirmatory] | |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | IC50 | 5.87 [uM] | | BioAssay | A High Throughput Confirmatory Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in the absence of Glycerol | | AID | 449764 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 23 | [SID49681832] | Active | EC50 | 8.035 | Fluorescence Polarization Cell-Free Homogeneous Dose Retest to Confirm Inhibitors of the LANA Histone H2A/H2B Interaction [AID435023, Type: confirmatory] | LANA [Human herpesvirus 8] [gi:139472804] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | EC50 | 8.035 [uM] | | BioAssay | Fluorescence Polarization Cell-Free Homogeneous Dose Retest to Confirm Inhibitors of the LANA Histone H2A/H2B Interaction | | AID | 435023 | | BioAssay type | confirmatory | | Target | LANA [Human herpesvirus 8] [gi:139472804] | | PubMed | | | Data Table |  |
|
| 24 | [SID49681832] | Active | Potency | 8.9125 | qHTS for Inhibitors of ATXN expression [AID651635, Type: confirmatory] | ATXN2 gene product [Homo sapiens] [gi:171543895] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | Potency | 8.9125 [uM] | | BioAssay | qHTS for Inhibitors of ATXN expression | | AID | 651635 | | BioAssay type | confirmatory | | Target | ATXN2 gene product [Homo sapiens] [gi:171543895] | | PubMed | | | Data Table |  |
|
| 25 | [SID49681832] | Active | IC50 | 10.5 | Dose response confirmation of uHTS of chemical inhibitors of both B-cell and T-cell specific antigen receptor-induced NF-kB activation in a Jurkat cell line using a luminescence assay [AID489004, Type: confirmatory] | |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | IC50 | 10.5 [uM] | | BioAssay | Dose response confirmation of uHTS of chemical inhibitors of both B-cell and T-cell specific antigen receptor-induced NF-kB activation in a Jurkat cell line using a luminescence assay | | AID | 489004 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 26 | [SID49681832] | Active | IC50 | 14.91 | High Throughput Screen to Identify Inhibitors of Mycobacterium tuberculosis H37Rv [AID1626, Type: confirmatory] | |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | IC50 | 14.91 [uM] | | BioAssay | High Throughput Screen to Identify Inhibitors of Mycobacterium tuberculosis H37Rv | | AID | 1626 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 27 | [SID49681832] | Active | CC50 | 18.701 | A Cell Based Secondary Assay To Explore Cytotoxicity of Compounds that Inhibit Mycobacterium Tuberculosis [AID435019, Type: confirmatory] | |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | CC50 | 18.701 [uM] | | BioAssay | A Cell Based Secondary Assay To Explore Cytotoxicity of Compounds that Inhibit Mycobacterium Tuberculosis | | AID | 435019 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 28 | [SID49681832] | Active | Potency | 39.8107 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | Potency | 39.8107 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 29 | [SID49681832] | Active | Potency | 39.8107 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | Potency | 39.8107 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 30 | [SID49681832] | Active | Potency | 56.2341 | qHTS for Inhibitors of WRN Helicase [AID651768, Type: confirmatory] | WRN [Homo sapiens] [gi:3719421] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | Potency | 56.2341 [uM] | | BioAssay | qHTS for Inhibitors of WRN Helicase | | AID | 651768 | | BioAssay type | confirmatory | | Target | WRN [Homo sapiens] [gi:3719421] | | PubMed | | | Data Table |  |
|
| 31 | [SID49681832] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH; PLA2G7) [AID463230, Type: screening] | PLA2G7 gene product [Homo sapiens] [gi:270133071] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH; PLA2G7) | | AID | 463230 | | BioAssay type | screening | | Target | PLA2G7 gene product [Homo sapiens] [gi:270133071] | | PubMed | | | Data Table |  |
|
| 32 | [SID49681832] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH; PLA2G7) [AID463230, Type: screening] | PLA2G7 gene product [Homo sapiens] [gi:270133071] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH; PLA2G7) | | AID | 463230 | | BioAssay type | screening | | Target | PLA2G7 gene product [Homo sapiens] [gi:270133071] | | PubMed | | | Data Table |  |
|
| 33 | [SID49681832] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) [AID463082, Type: screening] | PLA2G7 gene product [Homo sapiens] [gi:270133071] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) | | AID | 463082 | | BioAssay type | screening | | Target | PLA2G7 gene product [Homo sapiens] [gi:270133071] | | PubMed | | | Data Table |  |
|
| 34 | [SID49681832] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) [AID463082, Type: screening] | PLA2G7 gene product [Homo sapiens] [gi:270133071] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) | | AID | 463082 | | BioAssay type | screening | | Target | PLA2G7 gene product [Homo sapiens] [gi:270133071] | | PubMed | | | Data Table |  |
|
| 35 | [SID49681832] | Active | | | uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay [AID624354, Type: screening] | TNFRSF10B gene product [Homo sapiens] [gi:224494019] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | BioAssay | uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay | | AID | 624354 | | BioAssay type | screening | | Target | TNFRSF10B gene product [Homo sapiens] [gi:224494019] | | PubMed | | | Data Table |  |
|
| 36 | [SID49681832] | Active | | | uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay [AID624354, Type: screening] | TNFRSF10B gene product [Homo sapiens] [gi:224494019] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | BioAssay | uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay | | AID | 624354 | | BioAssay type | screening | | Target | TNFRSF10B gene product [Homo sapiens] [gi:224494019] | | PubMed | | | Data Table |  |
|
| 37 | [SID49681832] | Active | | | Homologous recombination - Rad 51 [AID1385, Type: screening] | RAD51 [Homo sapiens] [gi:49168602] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | BioAssay | Homologous recombination - Rad 51 | | AID | 1385 | | BioAssay type | screening | | Target | RAD51 [Homo sapiens] [gi:49168602] | | PubMed | | | Data Table |  |
|
| 38 | [SID49681832] | Active | | | Homologous recombination - Rad 51 [AID1385, Type: screening] | RAD51 [Homo sapiens] [gi:49168602] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | BioAssay | Homologous recombination - Rad 51 | | AID | 1385 | | BioAssay type | screening | | Target | RAD51 [Homo sapiens] [gi:49168602] | | PubMed | | | Data Table |  |
|
| 39 | [SID49681832] | Active | | | uHTS identification of SUMO1-mediated protein-protein interactions [AID602429, Type: screening] | SUMO-1 [Homo sapiens] [gi:1762973] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | BioAssay | uHTS identification of SUMO1-mediated protein-protein interactions | | AID | 602429 | | BioAssay type | screening | | Target | SUMO-1 [Homo sapiens] [gi:1762973] | | PubMed | | | Data Table |  |
|
| 40 | [SID49681832] | Active | | | Inhibitors of Cav3 T-type Calcium Channels: Primary Screen [AID449739, Type: screening] | voltage-dependent T-type calcium channel subunit alpha-1H isoform a [Homo sapiens] [gi:53832009] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | BioAssay | Inhibitors of Cav3 T-type Calcium Channels: Primary Screen | | AID | 449739 | | BioAssay type | screening | | Target | voltage-dependent T-type calcium channel subunit alpha-1H isoform a [Homo sapiens] [gi:53832009] | | PubMed | | | Data Table |  |
|
| 41 | [SID49681832] | Active | | | Inhibitors of Cav3 T-type Calcium Channels: Primary Screen [AID449739, Type: screening] | voltage-dependent T-type calcium channel subunit alpha-1H isoform a [Homo sapiens] [gi:53832009] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | BioAssay | Inhibitors of Cav3 T-type Calcium Channels: Primary Screen | | AID | 449739 | | BioAssay type | screening | | Target | voltage-dependent T-type calcium channel subunit alpha-1H isoform a [Homo sapiens] [gi:53832009] | | PubMed | | | Data Table |  |
|
| 42 | [SID49681832] | Active | | | Inhibitors of Cav3 T-type Calcium Channels: Primary Screen [AID449739, Type: screening] | voltage-dependent T-type calcium channel subunit alpha-1H isoform a [Homo sapiens] [gi:53832009] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | BioAssay | Inhibitors of Cav3 T-type Calcium Channels: Primary Screen | | AID | 449739 | | BioAssay type | screening | | Target | voltage-dependent T-type calcium channel subunit alpha-1H isoform a [Homo sapiens] [gi:53832009] | | PubMed | | | Data Table |  |
|
| 43 | [SID49681832] | Active | | | uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay [AID588413, Type: screening] | Gli1 [Mus musculus] [gi:6009644] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | BioAssay | uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay | | AID | 588413 | | BioAssay type | screening | | Target | Gli1 [Mus musculus] [gi:6009644] | | PubMed | | | Data Table |  |
|
| 44 | [SID49681832] | Active | | | uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay [AID588413, Type: screening] | Gli1 [Mus musculus] [gi:6009644] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | BioAssay | uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay | | AID | 588413 | | BioAssay type | screening | | Target | Gli1 [Mus musculus] [gi:6009644] | | PubMed | | | Data Table |  |
|
| 45 | [SID49681832] | Active | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1). [AID2098, Type: screening] | Hsf1 protein [Mus musculus] [gi:62740231] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1). | | AID | 2098 | | BioAssay type | screening | | Target | Hsf1 protein [Mus musculus] [gi:62740231] | | PubMed | | | Data Table |  |
|
| 46 | [SID49681832] | Active | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1). [AID2098, Type: screening] | Hsf1 protein [Mus musculus] [gi:62740231] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1). | | AID | 2098 | | BioAssay type | screening | | Target | Hsf1 protein [Mus musculus] [gi:62740231] | | PubMed | | | Data Table |  |
|
| 47 | [SID49681832] | Active | | | uHTS Fluorescent Assay Using Nedd8 Protein Substrate for Identification of Inhibitors of Sentrin-Specific Protease 8 (SENP8) [AID602440, Type: screening] | SENP8 gene product [Homo sapiens] [gi:262118306] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | BioAssay | uHTS Fluorescent Assay Using Nedd8 Protein Substrate for Identification of Inhibitors of Sentrin-Specific Protease 8 (SENP8) | | AID | 602440 | | BioAssay type | screening | | Target | SENP8 gene product [Homo sapiens] [gi:262118306] | | PubMed | | | Data Table |  |
|
| 48 | [SID49681832] | Active | | | Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). [AID1974, Type: screening] | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | BioAssay | Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). | | AID | 1974 | | BioAssay type | screening | | Target | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] | | PubMed | | | Data Table |  |
|
| 49 | [SID49681832] | Active | | | Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). [AID1974, Type: screening] | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | BioAssay | Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). | | AID | 1974 | | BioAssay type | screening | | Target | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] | | PubMed | | | Data Table |  |
|
| 50 | [SID49681832] | Active | | | Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1). [AID2174, Type: screening] | acyl-protein thioesterase 1 [Homo sapiens] [gi:5453722] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 49681832 | | CID | 65348 | | Outcome | Active | | BioAssay | Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1). | | AID | 2174 | | BioAssay type | screening | | Target | acyl-protein thioesterase 1 [Homo sapiens] [gi:5453722] | | PubMed | | | Data Table |  |
|